Discovery of potent and selective covalent inhibitors of JNK

Tinghu Zhang, Francisco Inesta-Vaquera, Mario Niepel, Jianming Zhang, Scott B. Ficarro, Thomas MacHleidt, Ting Xie, Jarrod A. Marto, Namdoo Kim, Taebo Sim, John D. Laughlin, Hajeung Park, Philip V. Lograsso, Matt Patricelli, Tyzoon K. Nomanbhoy, Peter K. Sorger, Dario R. Alessi, Nathanael S. Gray

Research output: Contribution to journalArticle

161 Citations (Scopus)

Abstract

The mitogen-activated kinases JNK1/2/3 are key enzymes in signaling modules that transduce and integrate extracellular stimuli into coordinated cellular response. Here, we report the discovery of irreversible inhibitors of JNK1/2/3. We describe two JNK3 cocrystal structures at 2.60 and 2.97 resolution that show the compounds form covalent bonds with a conserved cysteine residue. JNK-IN-8 is a selective JNK inhibitor that inhibits phosphorylation of c-Jun, a direct substrate of JNK, in cells exposed to submicromolar drug in a manner that depends on covalent modification of the conserved cysteine residue. Extensive biochemical, cellular, and pathway-based profiling establish the selectivity of JNK-IN-8 for JNK and suggests that the compound will be broadly useful as a pharmacological probe of JNK-dependent signal transduction. Potential lead compounds have also been identified for kinases, including IRAK1, PIK3C3, PIP4K2C, and PIP5K3.

Original languageEnglish
Pages (from-to)140-154
Number of pages15
JournalChemistry and Biology
Volume19
Issue number1
DOIs
Publication statusPublished - 2012 Jan 27

Fingerprint

Cysteine
Mitogen-Activated Protein Kinase 8
Lead compounds
Signal transduction
Phosphorylation
Covalent bonds
Mitogens
Signal Transduction
Phosphotransferases
Pharmacology
Substrates
Enzymes
Pharmaceutical Preparations
Lead

ASJC Scopus subject areas

  • Biochemistry
  • Drug Discovery
  • Molecular Biology
  • Clinical Biochemistry
  • Molecular Medicine
  • Pharmacology

Cite this

Zhang, T., Inesta-Vaquera, F., Niepel, M., Zhang, J., Ficarro, S. B., MacHleidt, T., ... Gray, N. S. (2012). Discovery of potent and selective covalent inhibitors of JNK. Chemistry and Biology, 19(1), 140-154. https://doi.org/10.1016/j.chembiol.2011.11.010

Discovery of potent and selective covalent inhibitors of JNK. / Zhang, Tinghu; Inesta-Vaquera, Francisco; Niepel, Mario; Zhang, Jianming; Ficarro, Scott B.; MacHleidt, Thomas; Xie, Ting; Marto, Jarrod A.; Kim, Namdoo; Sim, Taebo; Laughlin, John D.; Park, Hajeung; Lograsso, Philip V.; Patricelli, Matt; Nomanbhoy, Tyzoon K.; Sorger, Peter K.; Alessi, Dario R.; Gray, Nathanael S.

In: Chemistry and Biology, Vol. 19, No. 1, 27.01.2012, p. 140-154.

Research output: Contribution to journalArticle

Zhang, T, Inesta-Vaquera, F, Niepel, M, Zhang, J, Ficarro, SB, MacHleidt, T, Xie, T, Marto, JA, Kim, N, Sim, T, Laughlin, JD, Park, H, Lograsso, PV, Patricelli, M, Nomanbhoy, TK, Sorger, PK, Alessi, DR & Gray, NS 2012, 'Discovery of potent and selective covalent inhibitors of JNK', Chemistry and Biology, vol. 19, no. 1, pp. 140-154. https://doi.org/10.1016/j.chembiol.2011.11.010
Zhang T, Inesta-Vaquera F, Niepel M, Zhang J, Ficarro SB, MacHleidt T et al. Discovery of potent and selective covalent inhibitors of JNK. Chemistry and Biology. 2012 Jan 27;19(1):140-154. https://doi.org/10.1016/j.chembiol.2011.11.010
Zhang, Tinghu ; Inesta-Vaquera, Francisco ; Niepel, Mario ; Zhang, Jianming ; Ficarro, Scott B. ; MacHleidt, Thomas ; Xie, Ting ; Marto, Jarrod A. ; Kim, Namdoo ; Sim, Taebo ; Laughlin, John D. ; Park, Hajeung ; Lograsso, Philip V. ; Patricelli, Matt ; Nomanbhoy, Tyzoon K. ; Sorger, Peter K. ; Alessi, Dario R. ; Gray, Nathanael S. / Discovery of potent and selective covalent inhibitors of JNK. In: Chemistry and Biology. 2012 ; Vol. 19, No. 1. pp. 140-154.
@article{6a24277c571d46498514759618e2be14,
title = "Discovery of potent and selective covalent inhibitors of JNK",
abstract = "The mitogen-activated kinases JNK1/2/3 are key enzymes in signaling modules that transduce and integrate extracellular stimuli into coordinated cellular response. Here, we report the discovery of irreversible inhibitors of JNK1/2/3. We describe two JNK3 cocrystal structures at 2.60 and 2.97 resolution that show the compounds form covalent bonds with a conserved cysteine residue. JNK-IN-8 is a selective JNK inhibitor that inhibits phosphorylation of c-Jun, a direct substrate of JNK, in cells exposed to submicromolar drug in a manner that depends on covalent modification of the conserved cysteine residue. Extensive biochemical, cellular, and pathway-based profiling establish the selectivity of JNK-IN-8 for JNK and suggests that the compound will be broadly useful as a pharmacological probe of JNK-dependent signal transduction. Potential lead compounds have also been identified for kinases, including IRAK1, PIK3C3, PIP4K2C, and PIP5K3.",
author = "Tinghu Zhang and Francisco Inesta-Vaquera and Mario Niepel and Jianming Zhang and Ficarro, {Scott B.} and Thomas MacHleidt and Ting Xie and Marto, {Jarrod A.} and Namdoo Kim and Taebo Sim and Laughlin, {John D.} and Hajeung Park and Lograsso, {Philip V.} and Matt Patricelli and Nomanbhoy, {Tyzoon K.} and Sorger, {Peter K.} and Alessi, {Dario R.} and Gray, {Nathanael S.}",
year = "2012",
month = "1",
day = "27",
doi = "10.1016/j.chembiol.2011.11.010",
language = "English",
volume = "19",
pages = "140--154",
journal = "Cell Chemical Biology",
issn = "2451-9448",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Discovery of potent and selective covalent inhibitors of JNK

AU - Zhang, Tinghu

AU - Inesta-Vaquera, Francisco

AU - Niepel, Mario

AU - Zhang, Jianming

AU - Ficarro, Scott B.

AU - MacHleidt, Thomas

AU - Xie, Ting

AU - Marto, Jarrod A.

AU - Kim, Namdoo

AU - Sim, Taebo

AU - Laughlin, John D.

AU - Park, Hajeung

AU - Lograsso, Philip V.

AU - Patricelli, Matt

AU - Nomanbhoy, Tyzoon K.

AU - Sorger, Peter K.

AU - Alessi, Dario R.

AU - Gray, Nathanael S.

PY - 2012/1/27

Y1 - 2012/1/27

N2 - The mitogen-activated kinases JNK1/2/3 are key enzymes in signaling modules that transduce and integrate extracellular stimuli into coordinated cellular response. Here, we report the discovery of irreversible inhibitors of JNK1/2/3. We describe two JNK3 cocrystal structures at 2.60 and 2.97 resolution that show the compounds form covalent bonds with a conserved cysteine residue. JNK-IN-8 is a selective JNK inhibitor that inhibits phosphorylation of c-Jun, a direct substrate of JNK, in cells exposed to submicromolar drug in a manner that depends on covalent modification of the conserved cysteine residue. Extensive biochemical, cellular, and pathway-based profiling establish the selectivity of JNK-IN-8 for JNK and suggests that the compound will be broadly useful as a pharmacological probe of JNK-dependent signal transduction. Potential lead compounds have also been identified for kinases, including IRAK1, PIK3C3, PIP4K2C, and PIP5K3.

AB - The mitogen-activated kinases JNK1/2/3 are key enzymes in signaling modules that transduce and integrate extracellular stimuli into coordinated cellular response. Here, we report the discovery of irreversible inhibitors of JNK1/2/3. We describe two JNK3 cocrystal structures at 2.60 and 2.97 resolution that show the compounds form covalent bonds with a conserved cysteine residue. JNK-IN-8 is a selective JNK inhibitor that inhibits phosphorylation of c-Jun, a direct substrate of JNK, in cells exposed to submicromolar drug in a manner that depends on covalent modification of the conserved cysteine residue. Extensive biochemical, cellular, and pathway-based profiling establish the selectivity of JNK-IN-8 for JNK and suggests that the compound will be broadly useful as a pharmacological probe of JNK-dependent signal transduction. Potential lead compounds have also been identified for kinases, including IRAK1, PIK3C3, PIP4K2C, and PIP5K3.

UR - http://www.scopus.com/inward/record.url?scp=84863056297&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863056297&partnerID=8YFLogxK

U2 - 10.1016/j.chembiol.2011.11.010

DO - 10.1016/j.chembiol.2011.11.010

M3 - Article

C2 - 22284361

AN - SCOPUS:84863056297

VL - 19

SP - 140

EP - 154

JO - Cell Chemical Biology

JF - Cell Chemical Biology

SN - 2451-9448

IS - 1

ER -